InnAVasc Overview

  • Founded

  • 2013

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 8

Employees
  • Latest Deal Type

  • M&A

  • Investors

  • 1

InnAVasc General Information

Description

Manufacturer of medical devices created to offer vascular access for hemodialysis. The company's devices modify existing synthetic vascular grafts for hemodialysis access, prevent needle cannulation injuries and facilitate graft access safety, enabling physicians to reduce the potential for adverse events and device failures associated with repeated vascular access.

Contact Information

Website
www.innavasc.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Parent Company
W. L. Gore and Associates
Primary Office
  • 110 Swift Avenue
  • Durham, NC 27705
  • United States
+1 (919) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InnAVasc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 17-Aug-2022 00.000 Completed Generating Revenue
8. Later Stage VC 09-Nov-2021 00.000 00.000 Completed Generating Revenue
7. Debt - General 17-Jul-2019 00000 00.00 Completed Generating Revenue
6. Seed Round 10-Oct-2018 000 00.00 000.00 Completed Generating Revenue
5. Grant 01-Jan-2017 00.000 00.00 Completed Generating Revenue
4. Seed Round 04-Nov-2016 00.000 00.00 00.000 Completed Generating Revenue
3. Debt - General 09-Sep-2016 00000 00000 Completed Generating Revenue
2. Grant 01-Sep-2016 $1000K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view InnAVasc’s complete valuation and funding history, request access »

InnAVasc Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 2 000,000 00.00 00.00 00 00.00 0.000
Seed 1 0,000,000 00.00 00.00 00 00.00 00.000
To view InnAVasc’s complete cap table history, request access »

InnAVasc Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of medical devices created to offer vascular access for hemodialysis. The company's devices modify existing
Surgical Devices
Durham, NC
8 As of 2022
00.000
000000&0 00.000

000000

em ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor inci
00000 0000000 000 00
San Antonio, TX
0 As of 0000
000.00
000 0000-00-00
0000000000 0 000.00

000000

etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
00000000000 0000000
Tel Aviv, Israel
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InnAVasc Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bluegrass Vascular Technologies Venture Capital-Backed San Antonio, TX 0 000.00 0000000000 0 000.00
00000000 0000000 0 Venture Capital-Backed Tel Aviv, Israel 00 0000 00000000000 0000
You’re viewing 2 of 2 competitors. Get the full list »

InnAVasc Patents

  • 16

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

InnAVasc Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220305183-A1 Vascular arteriovenous graft Pending 26-Mar-2021 0000000000 0
US-20220304725-A1 Apparatus and method for implanting an arteriovenous graft Pending 26-Mar-2021 0000000000
US-20210322193-A1 Apparatus and method for implanting an arteriovenous graft Pending 20-Dec-2018 000000000
US-20200197205-A1 Apparatus and method for implanting an arteriovenous graft Active 20-Dec-2018 000000000 0
US-11045339-B2 Apparatus and method for implanting an arteriovenous graft Active 20-Dec-2018 A61M1/3655
To view InnAVasc’s complete patent history, request access »

InnAVasc Executive Team (6)

Name Title Board Seat Contact Info
Joseph Knight Ph.D President & Chief Executive Officer
Craig Nichols Director of Product Development & Regulatory Affairs
Shawn Gage Co-Founder & Director of Clinical Operations
Robert O'Reilly Business Developer
Roberto Manson MD Co-Founder & Vice President, Clinical Operations
You’re viewing 5 of 6 executive team members. Get the full list »

InnAVasc Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnAVasc Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Ariel Savannah Angel Partners Angel Group 000 0000 000000 0
Duke Angel Network Venture Capital Minority 000 0000 000000 0
Duke University Endowment Limited Partner 000 0000 000000 0
Fox Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial